Lexapro (Escitalopram)

Lexapro is the SSRI I start with most of the time, and the reason is boring...

Sections

1. What it actually does
2. The patient-autonomy piece, because it should be said up front
3. Dosing in plain language
4. Side effects, in plain language, in the order they actually come up
5. What’s nice to hear about it
6. Where it falls short
7. How it stacks up against the rest of the SSRI shelf
8. The pattern that ends up on Lexapro
9. What not to do
10. Bottom line
11. Sources

Lexapro is the SSRI I start with most of the time, and the reason is boring… it’s clean, it’s been around long enough that we know what it does, and it doesn’t usually do the dumb stuff that makes guys quit antidepressants in week three. That’s about it. People want a more interesting answer and there isn’t one.

It’s the active half of Celexa (citalopram), which is to say someone took Celexa, threw out the half that wasn’t doing much, and sold what was left as a new drug. Pharma being pharma. The upside for us is the dose-response is cleaner and the QT-prolongation issue that haunts Celexa above 40 mg (QT is a measurement on a heart-rhythm tracing, and Celexa at high doses can stretch it out in a way that’s worth watching, which is why you get an EKG at higher Celexa doses) basically goes away at Lexapro doses, so I can move the dose without doing an EKG every time.

What it actually does

It blocks the serotonin transporter, which means more serotonin sticks around in the gap between brain cells, and over the course of weeks that triggers something further along we still don’t fully understand. People who tell you they do understand the mechanism are lying. The serotonin-hypothesis-of-depression thing got dunked on a few years back for good reason… it’s not that simple, the receptor changes take weeks, the timeline of when patients actually feel better doesn’t match the timeline of when serotonin levels shift, which means there’s something else going on that we haven’t characterized yet. Doesn’t matter for our purposes. The drug works for a lot of people, we don’t need a perfect mechanism story to use it.

The patient-autonomy piece, because it should be said up front

Before we get into the dosing and the side effects, the bigger thing: if you want to try Lexapro, you get to try it. I’m a provider, not a parent. My job is to give you the honest take on what it’s likely to do for you and what the trade-offs are, your job is to decide what you actually want to do with that information. If you’ve heard the risks and you want the script, you get the script. The most I’ll do is make it a disapproving yes for cases where I have reservations, which is rare with Lexapro because it’s about as clean as it gets in this drug class. I hardly ever say no.

Personal view, as one data point you can take or leave: most people who come in with depression don’t strictly need medication, the work itself (naming the actual problem, fixing sleep, dealing with the life situation the depression is wrapped around) does the heavy lifting for a lot of cases. Around sixty percent of my patients end up not on anything because we talked about it honestly and they wanted to see what they could do without it first. That’s a perfectly reasonable answer when the patient isn’t in crisis. Twenty or thirty percent ask for the medication anyway, which is also fine, and that’s the conversation this post is for.

Dosing in plain language

Start at 5 or 10 mg for a week, then up to 10 mg, which is where most guys end up. If 10 mg isn’t doing it after six to eight weeks at full dose, we go to 20 mg. I rarely push above 20 mg because the data up there isn’t great, you mostly trade benefit for side effects, and at that point I’d rather switch or augment than push.

The thing nobody tells you is that the first two weeks suck a little. You’re getting the side effects before you’re getting the benefit. Nausea, some sleep weirdness, sometimes a jittery anxious feeling that makes guys think the drug is making them worse… it’s not, it’s just the ramp-up, and if you can sit through three weeks you’re usually past it.

Side effects, in plain language, in the order they actually come up

Sexual side effects are the big one and the most common reason guys quit. Delayed orgasm, lower libido, sometimes you just can’t get there at all. It’s not in everyone, the studies say twenty to thirty percent but the real-world number is higher than that… probably half of guys notice something, a third notice enough to want to do something about it, and if you’re answering the intake questionnaire honestly you’re probably in that group. If it’s a problem we add bupropion (Wellbutrin) on top, which fixes it for a substantial fraction of people, or sometimes we just switch to Wellbutrin if the depression profile fits it.

Nausea in the first two weeks, take it with food, goes away on its own.

Some guys feel kind of out of it for a few weeks, like the volume on everything got turned down a notch… for most people that lifts, for a small group it doesn’t, and those are the guys we end up switching off Lexapro because feeling zombified for a year just to not be depressed isn’t actually a fix.

Weight gain happens but it’s modest and slow, usually three to seven pounds over a year, and a lot of it is appetite coming back as the depression lifts which is mechanically hard to separate from the drug itself doing something. If you were eating one meal a day because you were too depressed to cook and now you’re eating three, that’s not the drug, that’s just being a functioning human again, and the scale doesn’t care which one is going on.

What’s nice to hear about it

For the patient where Lexapro fits the depression, it works, and it works without much drama. The week-two-through-three rough patch passes, and then you start noticing small things. The morning is less heavy. The texts you’d been ignoring get answered. The first weekend in a year that doesn’t feel like you’re underwater. The wife notices it before you do. People come back at month two and say some version of, I forgot what it was like to actually look forward to things. That’s a real outcome that doesn’t show up on a rating scale and doesn’t show up in the side effects ledger, and it’s worth naming because the way antidepressant content tends to get written, you’d never know any of this stuff actually helps anybody.

Where it falls short

Lexapro is fine for moderate depression and anxiety. It is not a heavy hitter. If you’ve got severe depression of the lights-out, can’t-get-out-of-bed, suicidal-ideation flavor, Lexapro probably isn’t going to be enough on its own, and you should be having a real conversation about whether you also need a higher-tier intervention like an SNRI, augmentation with lithium or a low-dose atypical antipsychotic (newer antipsychotic, used at much lower doses for depression than they’d be at for actual psychosis), or actually TMS (transcranial magnetic stimulation, the magnet-pulse procedure for treatment-resistant cases) or ketamine.

It also doesn’t do much for the physical symptoms of depression, body pain, the fatigue that won’t budge, the bone-deep tired that doesn’t lift even after a weekend of sleeping in. SNRIs (Effexor, Cymbalta) tend to do more there because they hit norepinephrine on top of serotonin. If your depression looks more like pain and exhaustion than like sadness, Lexapro might not be your drug.

How it stacks up against the rest of the SSRI shelf

Sertraline (Zoloft) is the other top-of-the-list default. Data is comparable, side effect profile is comparable, sertraline has a wider dose range and is sometimes a better fit for guys with prominent OCD features who tend to do better at higher doses (150 to 200 mg) than Lexapro can comfortably reach. The GI side effects are slightly more pronounced on sertraline in the first weeks. Either is defensible as a first move and I’ll pick between them based on small clinical factors, not because one is obviously better.

Prozac (fluoxetine) has the longest half-life of the SSRIs, which is a feature for guys who miss doses (no real discontinuation effect from a missed day) and a bug if we ever need to switch to something else, because the washout period before starting an MAOI (older class of antidepressants with a strict food list, because eating aged cheese or fermented stuff on them can spike your blood pressure to dangerous levels) or certain other agents is five weeks instead of one. It’s also activating, which makes it useful for low-energy depression and a poor fit for anxious depression.

Paxil (paroxetine) I rarely start anymore. Sexual side effects are the worst in the class, the weight gain is more pronounced, and the discontinuation profile is the most miserable, with brain-zaps and flu-feeling that can drag on for weeks. If a patient is already on Paxil and stable, fine. I’m not starting anyone new on it in 2026 when there are cleaner options on the shelf.

The summary: Lexapro and sertraline are the workhorses, Prozac is for specific niches, Paxil is mostly legacy. The reasons to pick Lexapro specifically are the cleanest tolerability profile in the class and the dose-response being predictable enough that we usually land at 10 or 20 mg without much messing around. Another tick in the Lexapro-is-the-default column.

The pattern that ends up on Lexapro

The kind of guy who comes in for the first time is usually somebody whose wife told him he’d been a different person for about a year and she was tired of it. He didn’t disagree. Hadn’t seen a doctor in six years, was drinking three or four beers a night, sleeping like garbage, kept saying he was “just tired” the way guys do when they don’t have language for anything else.

The depression screen comes back moderate. We start 10 mg Lexapro, I tell him the first three weeks are going to suck and not to quit. Week two he texts that the nausea is killing him and he feels more anxious than before, I tell him to ride it. Week four he says he had two good weekends in a row, which he hadn’t done in a year. Week eight he’s back to lifting, drinking less without trying to, his wife told him over dinner that he was “back.” Sexual side effects show up around month three, we add 150 mg Wellbutrin in the morning, that fixes it. Two years later he’s still on the combination. That’s the pattern, not every story but a very common one.

If you can sit through three weeks you’re usually past the worst of the ramp-up.

What not to do

Don’t quit cold turkey. The discontinuation syndrome on Lexapro is milder than on Effexor or Paxil but it still exists, and the brain-zaps and flu-feeling thing for two weeks is avoidable if you taper. Even on the way off, drop the dose by 5 mg every two to four weeks, slower if you’ve been on it a long time.

Don’t drink heavily on it, not because there’s some catastrophic interaction, just because alcohol is a depressant and you’re on a medication for depression, the math doesn’t really pencil out, you’re going to feel worse on Monday and you’re going to blame the drug.

Don’t double up if you miss a dose. Just take the next day’s at the regular time.

Bottom line

Lexapro is the default first SSRI for a reason. It works for a lot of guys, the side effect profile is the most tolerable in the class, and if it doesn’t work we’ve still learned something about your depression and we’ve got somewhere to go next. It’s not a magic drug and the marketing made it sound cleaner than it is, but as starting points go, it’s the right one most of the time. The decision to go on it, or not, or to come off it later, is yours. I’m here for the honest take, not to make the choice for you.

Sources

1. U.S. Food and Drug Administration. Lexapro (escitalopram oxalate) Prescribing Information. NDA 021323/021365. FDA; 2023. FDA label.
2. Yin J, Song X, Wang C, Lin X, Miao M. Escitalopram versus other antidepressive agents for major depressive disorder: a systematic review and meta-analysis. BMC Psychiatry. 2023;23(1):876. PMID 38001423.
3. Cipriani A, Furukawa TA, Salanti G, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. 2018;391(10128):1357, 1366. PMID 29477251.